LiPKChowKMChoY, et al.ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int2022; 42: 110–153.
2.
PeerapornratanaSChariyavilaskulPKanjanabuchT, et al.Short-dwell cycling intraperitoneal cefazolin plus ceftazidime in peritoneal dialysis patients. Perit Dial Int2017; 37: 218–224.
3.
LamMFTangBSFChanTK, et al.Ampicillin-sulbactam and amikacin used as second-line antibiotics for patients with culture-negative peritonitis. Perit Dial Int2008; 28: 540–542.
4.
FitzpatrickMAEsterlyJSPostelnickMJ, et al.Successful treatment of extensively drug-resistant Acinetobacter baumannii peritoneal dialysis peritonitis with intraperitoneal Polymixin B and ampicillin-sulbactam. Ann Pharmacother2012; 46: e17.
LiPSzetoCCPirainoB, et al.ISPD peritonitis recommendations: 2016 update on Prevention and treatment. Perit Dial Int2016; 36: 481–508.
8.
LamELienYTKKraftWK, et al.Vancomycin in peritoneal dialysis: clinical pharmacology considerations in therapy. Perit Dial Int2020; 40: 384–393.
9.
LamELienYTKraftWK, et al.Intraperitoneal pharmacokinetics of vancomycin in patients on automated peritoneal dialysis. Clin Transl Sci15(3): 649–657. DOI: 10.1111/cts.13182.
